Increased glucose production in mice overexpressing human fructose-1,6-bisphosphatase in the liver

American Journal of Physiology - Endocrinology and Metabolism

Volumn 295, Issue 5, 2008, Pages

  Visinoni, Sherley ^a   Fam, Barbara C ^a   Blair, Amy ^a   Rantzau, Christian ^a   Lamont, Benjamin J ^a   Bouwman, Russell ^a   Watt, Matthew J ^b   Proietto, Joseph ^a   Favaloro, Jenny M ^a   Andrikopoulos, Sofianos ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Endogenous glucose production; Glucose intolerance

Indexed keywords

FRUCTOSE BISPHOSPHATASE; MESSENGER RNA; PREALBUMIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GLUCONEOGENESIS; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; HEMIZYGOSITY; HOMOZYGOSITY; INSULATOR ELEMENT; LIPID DIET; LIVER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENE; TRANSGENIC MOUSE; UPREGULATION;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIETARY FATS; EATING; FRUCTOSE-BISPHOSPHATASE; GENE EXPRESSION; GLUCOSE; GLUCOSE INTOLERANCE; GLUCOSE-6-PHOSPHATASE; HOMOZYGOTE; HUMANS; HYPOTHALAMUS; INSULIN; INSULIN RESISTANCE; LIVER; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PYRUVIC ACID;

EID: 57049168678     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.90552.2008     Document Type: Article

References (47)

1. Albers KM, Davis FE, Perrone TN, Lee EY, Liu Y, Vore M. Expression of an epidermal keratin protein in liver of transgenic mice causes structural and functional abnormalities. J Cell Biol 128: 157-169, 1995.
2. Andrikopoulos S, Proietto J. The biochemical basis of increased hepatic glucose production in a mouse model of type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 38: 1389-1396, 1995.
3. Andrikopoulos S, Rosella G, Gaskin E, Thorburn A, Kaczmarczyk S, Zajac J, Proietto J. Impaired regulation of hepatic fructose-1,6-bisphosphatase in the New Zealand obese mouse model of NIDDM. Diabetes 42: 1731-1736, 1993.
4. Basu R, Breda E, Oberg A, Powell C, Dalla Man C, Basu A, Vittone J, Klee G, Arora P, Jensen M, Toffolo G, Cobelli C, Rizza R. Mechanisms of the age-associated deterioration in glucose tolerance: contribution of alterations in insulin secretion, action, and clearance. Diabetes 52: 1738-1748, 2003.
5. Boden G, Chen X, Stein T. Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 280: E23-E30, 2001.
6. Chang AY, Schneider DI. Abnormalities in hepatic enzyme activities during development of diabetes in db mice. Diabetologia 6: 274-278, 1970.
7. Chung J, Bell A, Felsenfeld G. Characterisation of the chicken beta-globin insulator. Proc Natl Acad Sci USA 94: 575-580, 1997.
8. Consoli A, Nurjhan N, Capani F, Gerich J. Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM. Diabetes 38: 550-557, 1989.
9. Creutzfeldt W, Mende D, Willms B, Soling HD. Vascular basement membrane thickness in muscle of spiny mice and activities of glycolysis and gluconeogenesis in the liver of animals with spontaneous and experimental diabetes and of untreated human diabetics. Diabetologia 6: 356-360, 1970.
10. Erion MD, van Poelje PD, Dang Q, Kasibhatla SR, Potter SC, Reddy MR, Reddy KR, Jiang T, Lipscomb WN. MB06322 (CS-917): A potent and selective inhibitor of fructose 1,6-bisphosphatase for controlling gluconeogenesis in type 2 diabetes. Proc Natl Acad Sci USA 102: 7970-7975, 2005.
11. Frayn KN, Maycock PF. Skeletal muscle triacylglycerol in the rat: methods for sampling and measurement, and studies of biological variability. J Lipid Res 21: 139-144, 1980.
12. Gastaldelli A, Baldi S, Pettiti M, Toschi E, Camastra S, Natali A, Landau B, Ferrannini E. Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study. Diabetes 49: 1367-1373, 2000.
13. Guglielmi L, Le Bert M, Truffinet V, Cogne M, Denizot Y. Insulators to improve expression of a 3′IgH LCR-driven reporter gene in transgenic mouse models. Biochem Biophys Res Commun 307: 466-471, 2003.
14. Jamieson E, Chong MM, Steinberg GR, Jovanovska V, Fam BC, Bullen DV, Chen Y, Kemp BE, Proietto J, Kay TW, Andrikopoulos S. Socs1 deficiency enhances hepatic insulin signaling. J Biol Chem 280: 31516-31521, 2005.
15. Kelley D, Mokan M, Veneman T. Impaired postprandial glucose utilization in non-insulin-dependent diabetes mellitus. Metabolism 43: 1549-1557, 1994.
16. Lai C, Gum RJ, Daly M, Fry EH, Hutchins C, Abad-Zapatero C, von Geldern TW. Benzoxazole benzenesulfonamides as allosteric inhibitors of fructose-1,6-bisphosphatase. Bioorg Med Chem 16: 1807-1810, 2006.
17. Lamont B, Andrikopoulos S, Funkat A, Favaloro J, Ye J, Kraegen E, Howlett K, Zajac J, Proietto J. Peripheral insulin resistance develops in transgenic rats overexpressing phosphoenolpyruvate carboxykinase in the kidney. Diabetologia 46: 1338-1347, 2003.
18. Lamont B, Visinoni S, Fam B, Kebede M, Weinrich B, Papapostolou S, Massinet H, Proietto J, Favaloro J, Andrikopoulos S. Expression of human fructose-1,6-bisphosphatase in the liver of transgenic mice results in increased glycerol gluconeogenesis. Endocrinology 147: 2764-2772, 2006.
19. Magnusson I, Rothman D, Katz L, Shulman R, Shulman G. Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study. J Clin Invest 90: 1323-1327, 1992.
20. Mitrakou A, Kelley D, Mokan M, Veneman T, Pangburn T, Reilly J, Gerich J. Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. N Engl J Med 326: 22-29, 1992.
21. Nolan CJ, Proietto J. The feto-placental glucose steal phenomenon is a major cause of maternal metabolic adaptation during late pregnancy in the rat. Diabetologia 37: 976-984, 1994.
22. Nurjhan N, Consoli A, Gerich J. Increased lipolysis and its consequences on gluconeogenesis in non-insulin-dependent diabetes mellitus. J Clin Invest 89: 169-175, 1992.
23. Obici S, Zhang B, Karkanias G, Rossetti L. Hypothalamic insulin signaling is required for inhibition of glucose production. Nat Med 8: 1376-1382, 2002.
24. Okamoto H, Nakae J, Kitamura T, Park BC, Dragatsis I, Accili D. Transgenic rescue of insulin receptor-deficient mice. J Clin Invest 114: 214-223, 2004.
25. Pocai A, Lam TK, Gutierrez-Juarez R, Obici S, Schwartz GJ, Bryan J, Aguilar-Bryan L, Rossetti L. Hypothalamic K(ATP) channels control hepatic glucose production. Nature 434: 1026-1031, 2005.
26. Potts W, Tucker D, Wood H, Martin C. Chicken beta-globin 5′HS4 insulators function to reduce variability in transgenic founder mice. Biochem Biophys Res Commun 273: 1015-1018, 2000.
27. Puhakainen I, Koivisto V, Yki-Jarvinen H. Lipolysis and gluconeogenesis from glycerol are increased in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 75: 789-794, 1992.
28. Qiang W, Weigiang K, Qing Z, Pengju Z, Yi L. Aging impairs insulin-stimulated glucose uptake in rat skeletal muscle via suppressing AMPKalpha. Exp Mol Med 39: 535-543, 2007.
29. Roden M, Bernroider E. Hepatic glucose metabolism in humans - its role in health and disease. Best Pract Res Clin Endocrinol Metab 17: 365-383, 2003.
30. Rosella G, Zajac J, Baker L, Kaczmarczyk S, Andrikopoulos S, Adams T, Proietto J. Impaired glucose tolerance and increased weight gain in transgenic rats overexpressing a non-insulin-responsive phosphoenolpyruvate carboxykinase gene. Mol Endocrinol 9: 1396-1404, 1995.
31. Rosella G, Zajac J, Kaczmarczyk S, Andrikopoulos S, Proietto J. Impaired suppression of gluconeogenesis induced by overexpression of a noninsulin-responsive phosphoenolpyruvate carboxykinase gene. Mol Endocrinol 7: 1456-1462, 1993.
32. Seidman I, Horland A, Teebor G. Glycolytic and gluconeogenic enzyme activities in the hereditary obese-hyperglycemic syndrome and in acquired obesity. Diabetologia 6: 313-316, 1970.
33. Seidman I, Horland A, Teebor G. Hepatic glycolytic and gluconeogenic enzymes of the obese-hyperglycemic mouse. Biochim Biophys Acta 146: 600-603, 1967.
34. Singhal P, Caumo A, Carey PE, Cobelli C, Taylor R. Regulation of endogenous glucose production after a mixed meal in type 2 diabetes. Am J Physiol Endocrinol Metab 283: E275-E283, 2002.
35. Song S, Andrikopoulos S, Filippis C, Thorburn A, Khan D, Proietto J. Mechanism of fat-induced hepatic gluconeogenesis: effect of metformin. Am J Physiol Endocrinol Metab 281: E275-E282, 2001.
36. Stumvoll M, Meyer C, Mitrakou A, Nadkarni V, Gerich J. Renal glucose production and utilization: new aspects in humans. Diabetologia 40: 749-757, 1997.
37. Stumvoll M, Perriello G, Nurjhan N, Bucci A, Welle S, Jansson P, Dailey G, Bier D, Jenssen T, Gerich J. Glutamine and alanine metabolism in NIDDM. Diabetes 45: 863-868, 1996.
38. Sun Y, Liu S, Ferguson S. Phosphoenolpyruvate carboxykinase overexpression selectively attenuates insulin signaling and hepatic insulin sensitivity in transgenic mice. J Biol Chem 277: 23301-23307, 2002.
39. Taketomi S, Ishikawa E, Iwatsuka H. Lipogenic enzymes in two types of genetically obese animals, fatty rats and yellow KK mice. Horm Metab Res 7: 242-246, 1975.
40. Tannour-Louet M, Porteu A, Vaulont S, Kahn A, Vasseur-Cognet M. A tamoxifen-inducible chimeric Cre recombinase specifically effective in the fetal and adult mouse liver. Hepatology 35: 1072-1081, 2002.
41. Toft I, Jenssen T. Type 2 diabetic patients have increased gluconeogenic efficiency to substrate availability, but intact autoregulation of endogenous glucose production. Scand J Clin Lab Invest 65: 307-320, 2005.
42. Trinh K, O'Doherty R, Anderson P, Lange A, Newgard C. Perturbation of fuel homeostasis caused by overexpression of the glucose-6-phosphatase catalytic subunit in liver of normal rats. J Biol Chem 273: 31615-31620, 1998.
43. Valera A, Pujol A, Pelegrin M, Bosch F. Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 91: 9151-9154, 1994.
44. van Poelje PD, Potter SC, Chandramouli VC, Landau BR, Dang Q, Erion MD. Inhibition of fructose 1,6-bisphosphatase reduces excessive endogenous glucose production and attenuates hyperglycemia in Zucker diabetic fatty rats. Diabetes 55: 1747-1754, 2006.
45. von Geldern TW, Lai C, Gum RJ, Daly M, Sun C, Fry EH, Abad-Zapatero C. Benzoxazole benzenesulfonamides are novel allosteric inhibitors of fructose-1,6-bisphosphatase with a distinct binding mode. Bioorg Med Chem 16: 1811-1815, 2006.
46. Wang Y, DeMayo FJ, Tsai SY, O'Malley BW. Ligand-inducible and liver-specific target gene expression in transgenic mice. Nat Biotechnol 15: 239-243, 1997.
47. Yan C, Costa RH, Darnell JE Jr, Chen JD, Van Dyke TA. Distinct positive and negative elements control the limited hepatocyte and choroid plexus expression of transthyretin in transgenic mice. EMBO J 9: 869-878, 1990.